Aim Endothelial dysfunction is considered a premature indication of atherosclerosis and
vessel damage and is present in the postmenopausal period. This study compares the …

Aim: The goal of this study was to investigate the combined effects of raloxifene and
atorvastatin in aged ovariectomized rats during endothelial dysfunction and atherosclerotic …

Lack of an appropriate animal model has delayed the better understanding of mechanisms
related to higher cardiovascular risk in women after menopause. The aging female rat may …

The studies on hormone replacement therapy (HRT) in females with estrogen deficiency are
not conclusive. Thus, non-estrogen therapies, such as atorvastatin (ATO), could be new …

Objective Previous studies have shown that estrogen deficiency, arising in postmenopause,
promotes endothelial dysfunction. This study evaluated the effects of aerobic exercise …

Objectives: Estrogen replacement therapy (ERT) improves blood flow through various
mechanisms including an augmented release of nitric oxide (NO). We report on the long …

Several clinical studies have indicated that oestrogens have protective properties on the
cardiovascular system. Although the beneficial effect has been attributable, at least in part, to …

It has been shown recently that α-zearalenol, a resorcyclic acid lactone, prevents bone loss
in a rat model of postmenopausal bone loss. We have therefore investigated the effects of …

In this study, we tested whether estrogen deficiency is associated with oxidative stress and
decreased nitric oxide (NO) production, which could be responsible for an increased blood …

Postmenopausal women have more severe endothelial dysfunction than premenopausal
women. In the present study, we evaluated the possible beneficial effect of raloxifene …